Paul J. Eslinger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Paul J. Eslinger has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Prasanna Karunanayaka
Pennsylvania State University College of Medicine
5 shared publications - Xuemei Huang
Department of Neurology University of Virginia Charlottesville Virginia USA
4 shared publications - Mechelle M. Lewis
Department of Neurology, Translational Brain Research Center, Penn State College of Medicine, Hershey, PA, 17033, USA
3 shared publications Qing X. Yang
From the Departments of *Neurology, †Radiology (Center for NMR Research), ‡Pediatrics, and §Neural and Behavioral Sciences, College of Medicine, Pennsylvania State University, The Milton S. Hershey Medical Center, Philadelphia, PA
3 shared publicationsBiyar Ahmed
Department of Radiology, Penn State University College of Medicine , Hershey, PA
2 shared publicationsClaire V. Flaherty-Craig
2 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
An exploratory synthetic MRI-derived FLAIR–DIR contrast in olfactory–limbic regions in mild cognitive impairment
Background: Odor identification impairment is an early feature of Alzheimer's disease and predicts memory decline, but its microstructural basis remains unclear. Objective: To evaluate FD, a semi-quantitative synthetic magnetic resonance imaging (MRI)–derived Fluid-Attenuated Inversion Recovery (FLAIR)–Double Inversion Recovery (DIR) contrast, against myelin volume fraction (MVF) in olfactory–limbic brain regions of patients diagnosed with mild cognitive impairment (MCI). Methods: Sixteen healthy controls (HC) and 17 individuals diagnosed with MCI completed olfactory and cognitive testing and underwent 3T MRI using a QALAS sequence. MVF maps were generated and FD was computed as (FLAIR − DIR)/FLAIR. Group differences were examined in olfactory–limbic gray matter and associated white-matter tracts, and voxel-wise regression assessed FD–odor identification associations, including models adjusted for voxel-wise MVF. Region of interest and voxel-wise analyses were exploratory and largely uncorrected for multiple comparisons. Results: Compared with HC, MCI showed lower FD across olfactory–limbic gray matter and white-matter pathways, including hippocampus, amygdala, orbitofrontal cortex, thalamus and corpus callosum, whereas MVF differences were more limited. Better odor identification was associated with higher FD in hippocampal/parahippocampal regions and insula, persisting after MVF adjustment. MVF showed positive associations in the right parahippocampal gyrus, left thalamus and genu of the corpus callosum. In an exploratory secondary analysis reported in the Supplemental Material, FD-based classification exceeded chance but was not separable from age alone. Conclusions: FD is a semi-quantitative relaxation-contrast metric showing regional patterns partially distinct from MVF. These exploratory findings require replication in larger, demographically matched, biomarker-confirmed cohorts before FD can be regarded as a marker of early olfactory–limbic microstructural change in MCI.
- 23 October 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
Open AccessAn exploratory synthetic MRI-derived FLAIR–DIR contrast in olfactory–limbic regions in mild cognitive impairment
Background: Odor identification impairment is an early feature of Alzheimer's disease and predicts memory decline, but its microstructural basis remains unclear. Objective: To evaluate FD, a semi-quantitative synthetic magnetic resonance imaging (MRI)–derived Fluid-Attenuated Inversion Recovery (FLAIR)–Double Inversion Recovery (DIR) contrast, against myelin volume fraction (MVF) in olfactory–limbic brain regions of patients diagnosed with mild cognitive impairment (MCI). Methods: Sixteen healthy controls (HC) and 17 individuals diagnosed with MCI completed olfactory and cognitive testing and underwent 3T MRI using a QALAS sequence. MVF maps were generated and FD was computed as (FLAIR − DIR)/FLAIR. Group differences were examined in olfactory–limbic gray matter and associated white-matter tracts, and voxel-wise regression assessed FD–odor identification associations, including models adjusted for voxel-wise MVF. Region of interest and voxel-wise analyses were exploratory and largely uncorrected for multiple comparisons. Results: Compared with HC, MCI showed lower FD across olfactory–limbic gray matter and white-matter pathways, including hippocampus, amygdala, orbitofrontal cortex, thalamus and corpus callosum, whereas MVF differences were more limited. Better odor identification was associated with higher FD in hippocampal/parahippocampal regions and insula, persisting after MVF adjustment. MVF showed positive associations in the right parahippocampal gyrus, left thalamus and genu of the corpus callosum. In an exploratory secondary analysis reported in the Supplemental Material, FD-based classification exceeded chance but was not separable from age alone. Conclusions: FD is a semi-quantitative relaxation-contrast metric showing regional patterns partially distinct from MVF. These exploratory findings require replication in larger, demographically matched, biomarker-confirmed cohorts before FD can be regarded as a marker of early olfactory–limbic microstructural change in MCI.
- Open Access
Olfactory Network Functional Connectivity as a Marker for Parkinson’s Disease Severity
Olfactory impairment was assessed in akinetic-rigid (PDAR) and tremor-predominant (PDT) subtypes of Parkinson’s disease (PD), classified based on motor symptoms. Seventeen PDAR, fifteen PDT, and twenty-four cognitively normal (CN) participants completed the University of Pennsylvania Smell Identification Test (UPSIT). Groups were well-matched for age and demographic variables, with cognitive performance statistically controlled. Resting-state fMRI (rs-fMRI) and seed-based functional connectivity (FC) analyses were conducted to characterize olfactory network (ON) connectivity across groups. UPSIT scores were significantly lower in PDAR compared to PDT. Consistently, ON FC values were reduced in PDAR relative to both PDT and CN. FC of the primary olfactory cortex (POC) significantly differed between CN and the PD subtypes. Furthermore, connectivity in the orbitofrontal cortex and insula showed significant differences between PDAR and PDT, as well as between PDAR and CN. Notably, ON FC between the left hippocampus and the posterior cingulate cortex (PCC) also differed significantly between PDAR and PDT. These findings reveal distinct ON FC patterns across PDAR and PDT subtypes. Variations in UPSIT scores suggest that motor symptom subtype is associated with olfactory performance. Moreover, ON connectivity closely paralleled the UPSIT scores, reinforcing a neural basis for olfactory deficits in PD. Given the accelerated motor and cognitive decline often observed in the PDAR, these results support the potential of olfactory impairment as a clinical marker for disease severity.
Open AccessOlfactory Network Functional Connectivity as a Marker for Parkinson’s Disease Severity
Olfactory impairment was assessed in akinetic-rigid (PDAR) and tremor-predominant (PDT) subtypes of Parkinson’s disease (PD), classified based on motor symptoms. Seventeen PDAR, fifteen PDT, and twenty-four cognitively normal (CN) participants completed the University of Pennsylvania Smell Identification Test (UPSIT). Groups were well-matched for age and demographic variables, with cognitive performance statistically controlled. Resting-state fMRI (rs-fMRI) and seed-based functional connectivity (FC) analyses were conducted to characterize olfactory network (ON) connectivity across groups. UPSIT scores were significantly lower in PDAR compared to PDT. Consistently, ON FC values were reduced in PDAR relative to both PDT and CN. FC of the primary olfactory cortex (POC) significantly differed between CN and the PD subtypes. Furthermore, connectivity in the orbitofrontal cortex and insula showed significant differences between PDAR and PDT, as well as between PDAR and CN. Notably, ON FC between the left hippocampus and the posterior cingulate cortex (PCC) also differed significantly between PDAR and PDT. These findings reveal distinct ON FC patterns across PDAR and PDT subtypes. Variations in UPSIT scores suggest that motor symptom subtype is associated with olfactory performance. Moreover, ON connectivity closely paralleled the UPSIT scores, reinforcing a neural basis for olfactory deficits in PD. Given the accelerated motor and cognitive decline often observed in the PDAR, these results support the potential of olfactory impairment as a clinical marker for disease severity.
- 1 January 2024
- Published by Oxford University Press (OUP) in Chemical Senses
- Vol. 49
Monorhinal and birhinal odor processing in humans: an fMRI investigation
The olfactory nerve, also known as cranial nerve I, is known to have exclusive ipsilateral projections to primary olfactory cortical structures. However, the lateralization of olfactory processes is known to depend on the task and nature of stimuli. It still remains unclear whether olfactory system projections in humans also correspond to functional pathways during olfactory tasks without any trigeminal, perceptual, or cognitive-motor components. Twenty young healthy subjects with a normal sense of smell took part in an olfactory functional magnetic resonance imaging (fMRI) study. We used 2 types of nostril-specific stimulation, passive (no sniffing), and active (with sniffing), with phenyl ethyl alcohol, a pure olfactory stimulant, to investigate fMRI activity patterns in primary and secondary olfactory-related brain structures. Irrespective of the stimulated nostril and the type of stimulation, we detected symmetrical activity in primary and secondary olfactory-related brain structures such as the primary olfactory cortex, entorhinal cortex, and orbitofrontal cortex. In the absence of perceptual or cognitive-motor task demands, the perception of monorhinally presented pure odors is processed bilaterally in the brain.
- 1 January 2024
- Published by Oxford University Press (OUP) in Chemical Senses
- Vol. 49
Monorhinal and birhinal odor processing in humans: an fMRI investigation
The olfactory nerve, also known as cranial nerve I, is known to have exclusive ipsilateral projections to primary olfactory cortical structures. However, the lateralization of olfactory processes is known to depend on the task and nature of stimuli. It still remains unclear whether olfactory system projections in humans also correspond to functional pathways during olfactory tasks without any trigeminal, perceptual, or cognitive-motor components. Twenty young healthy subjects with a normal sense of smell took part in an olfactory functional magnetic resonance imaging (fMRI) study. We used 2 types of nostril-specific stimulation, passive (no sniffing), and active (with sniffing), with phenyl ethyl alcohol, a pure olfactory stimulant, to investigate fMRI activity patterns in primary and secondary olfactory-related brain structures. Irrespective of the stimulated nostril and the type of stimulation, we detected symmetrical activity in primary and secondary olfactory-related brain structures such as the primary olfactory cortex, entorhinal cortex, and orbitofrontal cortex. In the absence of perceptual or cognitive-motor task demands, the perception of monorhinally presented pure odors is processed bilaterally in the brain.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S16)
Cerebellum Hyperactivity and its cortical connectivity in Alzheimer’s Disease (AD) utilizing FDG PET and Resting State Functional Magnetic Resonance.
Background: The role of the cerebellum in Alzheimer’s disease (AD) is not fully understood. There are a few studies that have demonstrated impaired cortical – cerebellar connectivity in AD. Additionally, transgenic mouse studies clearly show amyloid‐β (Aβ) deposition in the cerebellum affecting synaptic transmission and plasticity, sometimes before plaque formation. To characterize metabolic activity in the cerebellum, we analyzed 18F‐fluorodeoxyglucose (FDG) positron emission tomography (PET) and resting‐state functional MRI (rs‐fMRI) data in AD, mild‐cognitive impaired (MCI), and age‐matched cognitively normal (CN) subjects from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Our focus was on the intrinsic functional connectivity of the cerebellum with three brain networks: the default mode network (DMN), dorsal attention network (DAN), and the primary olfactory cortex (POC) in the medial temporal lobe. We hypothesized that the resting state functional connectivity of cerebellar regions (that showed differential FDG metabolic activity) would exhibit impaired brain‐wide network connectivity.Method: A group of 272 ADNI subjects (CN = 80, MCI = 149, AD = 43) with FDG‐PET scans were analyzed in this study. All 272 subjects did not have consistent rs‐fMRI data therefore, we analyzed 160 subjects (CN = 80, MCI = 84, AD = 29) that had consistent rs‐fMRI data acquisition parameters. The PET preprocessing was performed in SPM12. Partial volume correction was performed using the Van‐Cittert deconvolution technique. The rs‐fMRI data was preprocessed in DPABI; PET and rs‐fMRI data were normalized to the Montreal Neurological Institute template. DMN and DAN masks were downloaded from neurovault.org. The Statistical analyses were performed in DPABI.Result: The SPM group analysis of PET data identified crus II, right cerebellum 4,5 and vermis lobule 6 as hyperactive (increased glucose metabolism) in AD and MCI compared to CN (Figure 1). Subsequent analyses identified brain regions within the DMN, DAN, and POC that are correlated with hyperactive cerebellar regions. Similarity analyses detected impaired resting state functional connectivity of hyperactive cerebellar regions with the three brain networks (Figure 2).Conclusion: The hyper‐metabolism in the cerebellum may reflect disruption of local and brain‐wide network connectivity due to neurodegeneration. Observed hyper‐metabolism may be related to inhibitory dynamics of the cerebellum — providing a hypothetical mechanism to explain the susceptibility of brain networks in AD.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S16)
Open AccessCerebellum Hyperactivity and its cortical connectivity in Alzheimer’s Disease (AD) utilizing FDG PET and Resting State Functional Magnetic Resonance.
Background: The role of the cerebellum in Alzheimer’s disease (AD) is not fully understood. There are a few studies that have demonstrated impaired cortical – cerebellar connectivity in AD. Additionally, transgenic mouse studies clearly show amyloid‐β (Aβ) deposition in the cerebellum affecting synaptic transmission and plasticity, sometimes before plaque formation. To characterize metabolic activity in the cerebellum, we analyzed 18F‐fluorodeoxyglucose (FDG) positron emission tomography (PET) and resting‐state functional MRI (rs‐fMRI) data in AD, mild‐cognitive impaired (MCI), and age‐matched cognitively normal (CN) subjects from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Our focus was on the intrinsic functional connectivity of the cerebellum with three brain networks: the default mode network (DMN), dorsal attention network (DAN), and the primary olfactory cortex (POC) in the medial temporal lobe. We hypothesized that the resting state functional connectivity of cerebellar regions (that showed differential FDG metabolic activity) would exhibit impaired brain‐wide network connectivity.Method: A group of 272 ADNI subjects (CN = 80, MCI = 149, AD = 43) with FDG‐PET scans were analyzed in this study. All 272 subjects did not have consistent rs‐fMRI data therefore, we analyzed 160 subjects (CN = 80, MCI = 84, AD = 29) that had consistent rs‐fMRI data acquisition parameters. The PET preprocessing was performed in SPM12. Partial volume correction was performed using the Van‐Cittert deconvolution technique. The rs‐fMRI data was preprocessed in DPABI; PET and rs‐fMRI data were normalized to the Montreal Neurological Institute template. DMN and DAN masks were downloaded from neurovault.org. The Statistical analyses were performed in DPABI.Result: The SPM group analysis of PET data identified crus II, right cerebellum 4,5 and vermis lobule 6 as hyperactive (increased glucose metabolism) in AD and MCI compared to CN (Figure 1). Subsequent analyses identified brain regions within the DMN, DAN, and POC that are correlated with hyperactive cerebellar regions. Similarity analyses detected impaired resting state functional connectivity of hyperactive cerebellar regions with the three brain networks (Figure 2).Conclusion: The hyper‐metabolism in the cerebellum may reflect disruption of local and brain‐wide network connectivity due to neurodegeneration. Observed hyper‐metabolism may be related to inhibitory dynamics of the cerebellum — providing a hypothetical mechanism to explain the susceptibility of brain networks in AD.
- Open Access
- 12 May 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (5) , 829
Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease
Current pharmacotherapy has limited efficacy and/or intolerable side effects in late-stage Parkinson’s disease (LsPD) patients whose daily life depends primarily on caregivers and palliative care. Clinical metrics inadequately gauge efficacy in LsPD patients. We explored if a D1/5 dopamine agonist would have efficacy in LsPD using a double-blind placebo-controlled crossover phase Ia/b study comparing the D1/5 agonist PF-06412562 to levodopa/carbidopa in six LsPD patients. Caregiver assessment was the primary efficacy measure because caregivers were with patients throughout the study, and standard clinical metrics inadequately gauge efficacy in LsPD. Assessments included standard quantitative scales of motor function (MDS-UPDRS-III), alertness (Glasgow Coma and Stanford Sleepiness Scales), and cognition (Severe Impairment and Frontal Assessment Batteries) at baseline (Day 1) and thrice daily during drug testing (Days 2–3). Clinicians and caregivers completed the clinical impression of change questionnaires, and caregivers participated in a qualitative exit interview. Blinded triangulation of quantitative and qualitative data was used to integrate findings. Neither traditional scales nor clinician impression of change detected consistent differences between treatments in the five participants who completed the study. Conversely, the overall caregiver data strongly favored PF-06412562 over levodopa in four of five patients. The most meaningful improvements converged on motor, alertness, and functional engagement. These data suggest for the first time that there can be useful pharmacological intervention in LsPD patients using D1/5 agonists and also that caregiver perspectives with mixed method analyses may overcome limitations using methods common in early-stage patients. The results encourage future clinical studies and understanding of the most efficacious signaling properties of a D1 agonist for this population.
- 12 May 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (5) , 829
Open AccessDopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease
Current pharmacotherapy has limited efficacy and/or intolerable side effects in late-stage Parkinson’s disease (LsPD) patients whose daily life depends primarily on caregivers and palliative care. Clinical metrics inadequately gauge efficacy in LsPD patients. We explored if a D1/5 dopamine agonist would have efficacy in LsPD using a double-blind placebo-controlled crossover phase Ia/b study comparing the D1/5 agonist PF-06412562 to levodopa/carbidopa in six LsPD patients. Caregiver assessment was the primary efficacy measure because caregivers were with patients throughout the study, and standard clinical metrics inadequately gauge efficacy in LsPD. Assessments included standard quantitative scales of motor function (MDS-UPDRS-III), alertness (Glasgow Coma and Stanford Sleepiness Scales), and cognition (Severe Impairment and Frontal Assessment Batteries) at baseline (Day 1) and thrice daily during drug testing (Days 2–3). Clinicians and caregivers completed the clinical impression of change questionnaires, and caregivers participated in a qualitative exit interview. Blinded triangulation of quantitative and qualitative data was used to integrate findings. Neither traditional scales nor clinician impression of change detected consistent differences between treatments in the five participants who completed the study. Conversely, the overall caregiver data strongly favored PF-06412562 over levodopa in four of five patients. The most meaningful improvements converged on motor, alertness, and functional engagement. These data suggest for the first time that there can be useful pharmacological intervention in LsPD patients using D1/5 agonists and also that caregiver perspectives with mixed method analyses may overcome limitations using methods common in early-stage patients. The results encourage future clinical studies and understanding of the most efficacious signaling properties of a D1 agonist for this population.
- 23 December 2022
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 65 (5) , 596-597
Investigating language, social cognition, and executive function in cerebral palsy outcomes
This commentary is on the original article by Burgess et al. on pages 674–682 of this issue.
- 23 December 2022
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 65 (5) , 596-597
Investigating language, social cognition, and executive function in cerebral palsy outcomes
This commentary is on the original article by Burgess et al. on pages 674–682 of this issue.
- Open Access
- 1 September 2021
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 128, 592-620
The neuroscience of social feelings: mechanisms of adaptive social functioning
- 1 September 2021
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 128, 592-620
Open AccessThe neuroscience of social feelings: mechanisms of adaptive social functioning
- 17 August 2020
- Published by Elsevier in Brain and Language
- Vol. 209, 104841
Lexical-semantic search related to side of onset and putamen volume in Parkinson’s disease
- 17 August 2020
- Published by Elsevier in Brain and Language
- Vol. 209, 104841
Lexical-semantic search related to side of onset and putamen volume in Parkinson’s disease
- Open Access
- 25 November 2019
- Published by MDPI AG in Brain Sciences
- Vol. 9 (12) , 338
Functional Connectivity between the Resting-State Olfactory Network and the Hippocampus in Alzheimer’s Disease
Olfactory impairment is associated with prodromal Alzheimer’s disease (AD) and is a risk factor for the development of dementia. AD pathology is known to disrupt brain regions instrumental in olfactory information processing, such as the primary olfactory cortex (POC), the hippocampus, and other temporal lobe structures. This selective vulnerability suggests that the functional connectivity (FC) between the olfactory network (ON), consisting of the POC, insula and orbital frontal cortex (OFC) (Tobia et al., 2016), and the hippocampus may be impaired in early stage AD. Yet, the development trajectory of this potential FC impairment remains unclear. Here, we used resting-state functional magnetic resonance imaging (rs-fMRI) data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to investigate FC changes between the ON and hippocampus in four groups: aged-matched cognitively normal (CN), early mild cognitive impairment (EMCI), late mild cognitive impairment (LMCI), and AD. FC was calculated using low frequency fMRI signal fluctuations in the ON and hippocampus (Tobia et al., 2016). We found that the FC between the ON and the right hippocampus became progressively disrupted across disease states, with significant differences between EMCI and LMCI groups. Additionally, there were no significant differences in gray matter hippocampal volumes between EMCI and LMCI groups. Lastly, the FC between the ON and hippocampus was significantly correlated with neuropsychological test scores, suggesting that it is related to cognition in a meaningful way. These findings provide the first in vivo evidence for the involvement of FC between the ON and hippocampus in AD pathology. Results suggest that functional connectivity (FC) between the olfactory network (ON) and hippocampus may be a sensitive marker for Alzheimer’s disease (AD) progression, preceding gray matter volume loss.
- 25 November 2019
- Published by MDPI AG in Brain Sciences
- Vol. 9 (12) , 338
Open AccessFunctional Connectivity between the Resting-State Olfactory Network and the Hippocampus in Alzheimer’s Disease
Olfactory impairment is associated with prodromal Alzheimer’s disease (AD) and is a risk factor for the development of dementia. AD pathology is known to disrupt brain regions instrumental in olfactory information processing, such as the primary olfactory cortex (POC), the hippocampus, and other temporal lobe structures. This selective vulnerability suggests that the functional connectivity (FC) between the olfactory network (ON), consisting of the POC, insula and orbital frontal cortex (OFC) (Tobia et al., 2016), and the hippocampus may be impaired in early stage AD. Yet, the development trajectory of this potential FC impairment remains unclear. Here, we used resting-state functional magnetic resonance imaging (rs-fMRI) data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to investigate FC changes between the ON and hippocampus in four groups: aged-matched cognitively normal (CN), early mild cognitive impairment (EMCI), late mild cognitive impairment (LMCI), and AD. FC was calculated using low frequency fMRI signal fluctuations in the ON and hippocampus (Tobia et al., 2016). We found that the FC between the ON and the right hippocampus became progressively disrupted across disease states, with significant differences between EMCI and LMCI groups. Additionally, there were no significant differences in gray matter hippocampal volumes between EMCI and LMCI groups. Lastly, the FC between the ON and hippocampus was significantly correlated with neuropsychological test scores, suggesting that it is related to cognition in a meaningful way. These findings provide the first in vivo evidence for the involvement of FC between the ON and hippocampus in AD pathology. Results suggest that functional connectivity (FC) between the olfactory network (ON) and hippocampus may be a sensitive marker for Alzheimer’s disease (AD) progression, preceding gray matter volume loss.